Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus

Diabetic Medicine

Volumn 24, Issue 10, 2007, Pages 1129-1135

  Pettitt, D J ^a   Ospina, P ^a   Howard, C ^b   Zisser, H ^a   Jovanovic, L ^a  

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

Diabetes; Insulin; Insulin analogues; Pregnancy

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ANTIBODY; INSULIN ASPART;

ADULT; ANTIGEN BINDING; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMMUNOGENICITY; INJECTION SITE REACTION; MEAL; OPEN STUDY; PREGNANCY DIABETES MELLITUS; PUERPERIUM; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SOMNOLENCE;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; TREATMENT OUTCOME;

EID: 34548755546     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02247.x     Document Type: Article

References (29)

1. Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 : S5 S20.
2. American Diabetes Association. Gestational diabetes mellitus (Position Statement). Diabetes Care 2004 27 : S88 S90.
3. Metzger BE, Coustan DM. Organizing Committee: Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998 21 : B161 B167.
4. O'Sullivan JB. Diabetes mellitus after GDM. Diabetes 1991 29 : 131 135.
5. Pallardo F, Herranz L, Garcia-Ingelmo T, Grande C, Martin-Vaquero P, Janez M et al. Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 1999 22 : 1053 1058.
6. Langer O, Mazze R. The relationship between large-for-gestational-age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol 1988 159 : 1478 1483.
7. Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998 21 : B79 B84.
8. Jovanovic L, Crues J, Durak E, Peterson CM. Magnetic resonance imaging in pregnancies complicated by diabetes predicts infant birth weight ratio and neonatal morbidity. Am J Perinatol 1993 10 : 432 437.
9. Hollingsworth DR, Cousins L. Endocrine and metabolic disorders. In Creasy RK, Resnik E eds. Maternal fetal medicine: principles and practice. Philadelphia : W.B. Saunders Co., 1984 : 833 896.
10. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2000 21 : S77 S79.
11. Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982 144 : 768 773.
12. Jovanovic L, Petersen CM, Reed GF, Metzger BE, Mills JL, Knopp RH et al. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol 1991 164 : 103 111.
13. Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992 15 : 1251 1257.
14. Jovanovic-Peterson L, Peterson CM. Rationale for prevention and treatment of glucose-mediated macrosomia: a protocol for gestational diabetes. Endocrine Prac 1996 2 : 118 129.
15. Menon RK, Cohen RM, Sperling MA, Cutfield WS, Mimouni F, Khoury JC. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus: its role in fetal macrosomia. N Engl J Med 1990 323 : 309 315.
16. Jovanovic L, Sanja I, Pettitt DJ, Hugo K, Gutierrez M, Bowsher RR, Bastyr EJ. The metabolic and immunologic effect of insulin lispro in gestational diabetes. Diabetes Care 1999 22 : 1422 1427.
17. Pettitt DJ, Ospina P, Kolaczynski JW, Jovanovic L. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 2003 26 : 183 186.
18. Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 2000 23 : 583 588.
19. Fineberg NS, Fineberg SE, Anderson JH, Birkett MA, Gibson RG, Hufferd S. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes 1996 45 : 1750 1754.
20. Ottesen J, Nilsson P, Jami J, Weilguny D, Durhrkop M, Bucchini D et al. The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia 1994 37 : 1178 1185.
21. Chow SC, Liu JF. Design and Analysis of Bioavailability and Bioequivalence Study Design, 2nd edn. New York : Marcel Dekker, 2000 : 8.
22. Lindholm A, McEwen J, Riis AP. Improved postprandial glycemic control with insulin aspart: a randomized double-blind cross-over trial in type 1 diabetes. Diabetes Care 1999 22 : 801 805.
23. Perriello G, Avogaro A, Bosi E. Superior meal-time glucose control with insulin aspart (NovoLog) compared with human insulin in both normal-weight and overweight people with type 2 diabetes - a randomized, stratified, double-blind, crossover trial. Novo Nordisk Book of Abstracts. American Diabetes Association 62nd Scientific Sessions, San Francisco, CA, 14 18 June 2002.
24. Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF et al. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin. Acta Diabetol 2000 37 : 41 46.
25. Jovanovic L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp RH, Aarons JH. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991 164 : 103 111.
26. Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992 15 : 1251 1257.
27. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, Evans AT. Postprandial versus pre-prandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995 333 : 1237 1241.
28. Setter SM, Corbett CF, Campbell RK, White JR. Insulin aspart: a new rapid-acting insulin analog. Ann Pharmacother 2000 34 : 1423 1431.
29. Boskovic R, Feig DS, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin lispro across the human placenta: in vitro perfusion studies. Diabetes Care 2003 26 : 1390 1394.